Balance Sheet
Cash Flow Statement
Amortization of GoodwillAmortizatization of IntangiblesCash from Financing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Onconetix (ONCO) Cash from Financing Activities (2023 - 2025)

Onconetix (ONCO) has disclosed Cash from Financing Activities for 2 consecutive years, with $1.3 million as the latest value for Q4 2024.

  • On a quarterly basis, Cash from Financing Activities changed N/A to $1.3 million in Q4 2024 year-over-year; TTM through Dec 2024 was $6.7 million, a 551.47% increase, with the full-year FY2024 number at $6.7 million, up 551.47% from a year prior.
  • Cash from Financing Activities was $1.3 million for Q4 2024 at Onconetix, up from $578643.0 in the prior quarter.
  • In the past five years, Cash from Financing Activities ranged from a high of $5.2 million in Q1 2024 to a low of -$343426.0 in Q2 2024.